Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Biontech Se ADR (BNTX)

Biontech Se ADR (BNTX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 16,732,074
  • Shares Outstanding, K 226,262
  • Annual Sales, $ 121,620 K
  • Annual Income, $ -200,540 K
  • 60-Month Beta N/A
  • Price/Sales 143.23
  • Price/Cash Flow N/A
  • Price/Book 35.24

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 6 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/20
See More
  • Average Estimate -0.29
  • Number of Estimates 3
  • High Estimate -0.25
  • Low Estimate -0.35
  • Prior Year N/A
  • Growth Rate Est. (year over year) -100.03%

Price Performance

See More
Period Period Low Period High Performance
1-Month
66.51 +6.45%
on 08/11/20
104.99 -32.57%
on 07/22/20
+0.44 (+0.63%)
since 07/10/20
3-Month
45.08 +57.05%
on 05/14/20
104.99 -32.57%
on 07/22/20
+20.82 (+41.66%)
since 05/11/20

Most Recent Stories

More News
5 Stocks in the Spotlight on Trump's Coronavirus Vaccine Optimism

Millions are pinning their hopes on a handful of drugmakers, which are into the final phases of their vaccine trial.

SNY : 51.26 (+0.69%)
DVAX : 7.19 (-7.70%)
PFE : 38.14 (-0.65%)
GILD : 68.31 (-0.29%)
MRNA : 70.44 (-2.18%)
LLY : 151.36 (-1.07%)
GSK : 41.44 (+1.22%)
AMGN : 236.55 (-0.68%)
ADPT : 37.43 (-0.45%)
BNTX : 70.77 (-4.30%)
BioNTech SE Sponsored ADR (BNTX) Stock Sinks As Market Gains: What You Should Know

In the latest trading session, BioNTech SE Sponsored ADR (BNTX) closed at $77, marking a -0.1% move from the previous day.

BNTX : 70.77 (-4.30%)
BioNTech (BNTX) to Report Q2 Earnings: What's in Store?

During BioNTech's (BNTX) upcoming Q2 earnings conference, investors will keep track of the advancement of its COVID-19 vaccine candidate being developed in partnership with Pfizer.

PFE : 38.14 (-0.65%)
BLUE : 63.76 (-3.06%)
ICPT : 54.57 (+3.29%)
BNTX : 70.77 (-4.30%)
The Zacks Analyst Blog Highlights: Eli Lilly, Moderna, Pfizer, Sanofi, GlaxoSmithKline and BioNTech

The Zacks Analyst Blog Highlights: Eli Lilly, Moderna, Pfizer, Sanofi, GlaxoSmithKline and BioNTech

SNY : 51.26 (+0.69%)
PFE : 38.14 (-0.65%)
MRNA : 70.44 (-2.18%)
LLY : 151.36 (-1.07%)
GSK : 41.44 (+1.22%)
BNTX : 70.77 (-4.30%)
Changing Approach to Testing Could Ease Burden on Healthcare Systems

, /PRNewswire/ -- The pandemic has drastically changed the world's social and economic landscape. Countries have shut down schools and businesses, restricted travel, postponed entertainment and sporting...

TOMDF : 0.1020 (-7.27%)
LLY : 151.36 (-1.07%)
VIR : 52.96 (-0.45%)
DVAX : 7.19 (-7.70%)
BNTX : 70.77 (-4.30%)
3 Blue Chip Dividends for a Weak Dollar

As the US dollar continues to weaken, investors should look to buy Blue Chip stocks, such as PFE, PM, and CVX to strengthen their portfolios. “Money printer go brrrrrrrrr !” This humorous...

PFE : 38.14 (-0.65%)
BNTX : 70.77 (-4.30%)
PM : 78.98 (+0.78%)
MO : 43.69 (+1.09%)
CVX : 91.25 (+1.69%)
RDS.B : 30.81 (+2.91%)
BP : 24.23 (+3.11%)
Pfizer and BioNTech to Supply Japan with 120 Million Doses of their BNT162 mRNA-based Vaccine Candidate

Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today announced an agreement with the Ministry of Health, Labour and Welfare (MHLW) in Japan to supply 120 million doses of BNT162 mRNA-based vaccine...

PFE : 38.14 (-0.65%)
BNTX : 70.77 (-4.30%)
Coronavirus Vaccine Efforts Key to Moderna (MRNA) Q2 Earnings

Moderna (MRNA) is progressing with coronavirus vaccine development. The company has initiated a late-stage study and investors will likely focus any preliminary data from the study

SNY : 51.26 (+0.69%)
PFE : 38.14 (-0.65%)
MRNA : 70.44 (-2.18%)
BNTX : 70.77 (-4.30%)
All Eyes on "The Swamp;" Plus Q2 Reports from PFE, MCD & More

Senate Republicans on Capitol Hill have unveiled their long-awaited stimulus package to replace the CARES Act, which expires at the end of this week. Also, the Fed begins a two-day session.

PFE : 38.14 (-0.65%)
MMM : 165.35 (+2.42%)
SBUX : 79.81 (+3.02%)
MCD : 207.27 (+1.54%)
EBAY : 54.86 (+0.90%)
V : 202.31 (+2.81%)
BNTX : 70.77 (-4.30%)
HEALS Act & Earnings Data Deluge

HEALS Act & Earnings Data Deluge

PFE : 38.14 (-0.65%)
MMM : 165.35 (+2.42%)
SBUX : 79.81 (+3.02%)
MCD : 207.27 (+1.54%)
EBAY : 54.86 (+0.90%)
V : 202.31 (+2.81%)
BNTX : 70.77 (-4.30%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 80% Buy with a Weakening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Trade BNTX with:

Business Summary

BioNTech SE is a biotechnology company. It develops and commercializes immunotherapies for cancer and other diseases. BioNTech SE is based in Mainz, Germany.

See More

Key Turning Points

2nd Resistance Point 80.42
1st Resistance Point 77.18
Last Price 70.66
1st Support Level 70.81
2nd Support Level 67.67

See More

52-Week High 105.00
Last Price 70.66
Fibonacci 61.8% 69.67
Fibonacci 50% 58.76
Fibonacci 38.2% 47.85
52-Week Low 12.52

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar